过去一年中添加的文章，按日期排序
Early treatment of acute or recently acquired hepatitis C-an important tool on the path to HCV elimination!
M Cornberg, H Wedemeyer - Hepatology, 2024 - journals.lww.com
34 天前 - … development of highly effective direct-acting antiviral agents (DAAs) to combat hepatitis
C virus … Therefore, data on pan-genotypic therapies such as sofosbuvir/velpatasvir (SOF/…
C virus … Therefore, data on pan-genotypic therapies such as sofosbuvir/velpatasvir (SOF/…
Commentary on A Pregnant Patient with a Positive Hepatitis C Antibody
TS Lorey - The Journal of Applied Laboratory Medicine, 2024 - academic.oup.com
47 天前 - … -B hepatitis was identified and named hepatitis C virus (… development of diagnostic
tests and curative drug therapy. … , only a third of patients with chronic HCV receive effective …
tests and curative drug therapy. … , only a third of patients with chronic HCV receive effective …
… Direct Acting Antivirals and Ezetimibe vs Longer Course of Direct Acting Antivirals to Prevent Hepatitis C Infection in Thoracic Transplant Recipients of Hepatitis C …
PK Burcham, T Fallah, BA Whitson… - The Journal of Heart …, 2024 - jhltonline.org
99 天前 - … Pan-genotypic direct acting antivirals (DAA) and HCV … However, the optimal
duration of this therapy has not been … development of donor specific antibodies post-transplant. …
duration of this therapy has not been … development of donor specific antibodies post-transplant. …
[HTML][HTML] And Then There Was One: HCV Elimination in the Coinfected Population
L Hynicka - 2024 - contagionlive.com
107 天前 - … The evolution of treatment for hepatitis C virus during the … The treatment of the
hepatitis C virus (HCV) has evolved … ), pangenotypic options with greater than 95% efficacy to …
hepatitis C virus (HCV) has evolved … ), pangenotypic options with greater than 95% efficacy to …
ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource‐limited settings
G Indolfi, RP Gonzalez‐Peralta… - Journal of Pediatric …, 2024 - Wiley Online Library
142 天前 - … to development and improvements in therapy. Direct-acting antiviral regimens are
safe and effective… Since 2017 high rates of HCV viral clearance with the various pangenotypic …
safe and effective… Since 2017 high rates of HCV viral clearance with the various pangenotypic …
Profile of Sofosbuvir and Velpatasvir Combination in the Treatment of Chronic Hepatitis C in Children and Adolescents: Current Evidence
D Brigham, MR Narkewicz - Therapeutics and Clinical Risk …, 2024 - Taylor & Francis
180 天前 - … Treatment for HCV has evolved to highly effective direct … SOF/VEL is a pangenotypic
DAA with primary clearance via the … of the hepatitis C virus in this vulnerable population. …
DAA with primary clearance via the … of the hepatitis C virus in this vulnerable population. …
Pharmacokinetic evaluation of sofosbuvir/velpatasvir for the treatment of Chronic Hepatitis C in pediatrics aged 3 and older
J Tuan, A Okoli, O Ogbuagu - Expert Opinion on Drug Metabolism & …, 2023 - Taylor & Francis
220 天前 - … drug development have resulted in simplified treatments, … for treatment of adults with
chronic hepatitis C virus genotypes … , and highly effective pan-genotypic regimen which has …
chronic hepatitis C virus genotypes … , and highly effective pan-genotypic regimen which has …
[PDF][PDF] Toward Global Viral Hepatitis Eradication by 2030: Challenges and Strategies
P Valva - Revista Argentina de Microbiología, 2023 - panel.aam.org.ar
282 天前 - … in new infections; and the development of a direct-acting … safe pan-genotypic
regimens not only provides effective … the landscape of hepatitis care and treatment, offering …
regimens not only provides effective … the landscape of hepatitis care and treatment, offering …
Pharmacokinetics, Tolerability, and Safety of Glecaprevir/Pibrentasvir Co‐formulated Bilayer Tablet Following Repeated Administration in Healthy Chinese Adults
…, Q Jiang, A Asatryan, NN Alami, C Yu… - … Drug Development, 2023 - Wiley Online Library
309 天前 - … , pan-genotypic fixed-dose combination regimen approved for the treatment of all
major genotypes of hepatitis C virus (… , together with existing global efficacy and safety data in …
major genotypes of hepatitis C virus (… , together with existing global efficacy and safety data in …
Direct-acting antiviral therapy for treatment of acute and recent hepatitis C virus infection: a narrative review
M Martinello, S Naggie, JK Rockstroh… - Clinical Infectious …, 2023 - academic.oup.com
330 天前 - … This article describes the natural history and management … safety and efficacy of
DAA therapy for the treatment of acute … Short-duration pan-genotypic therapy with glecaprevir/…
DAA therapy for the treatment of acute … Short-duration pan-genotypic therapy with glecaprevir/…